Infectious toxicities in patients treated with bispecific antibodies in multiple myeloma

被引：0
|
作者：
Saez, Adolfo [1 ]
Lopez-Munoz, Nieves [1 ]
Maria Sanchez-Pina, Jose [1 ]
Alonso, Rafael [1 ]
Cuellar, Clara [1 ]
Lazaro, Paula [1 ]
Jimenez Ubieto, Ana [1 ]
Calbacho, Maria [1 ]
Martinez Lopez, Joaquin [1 ]
机构：
[1] Hosp 12 Octubre, Madrid, Spain
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2022年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-113
引用
收藏
页码：S97 / S98
页数：2
相关论文
共 50 条
  • [21] STUDY OF INFECTIOUS COMPLICATIONS IN MULTIPLE MYELOMA PATIENTS TREATED WITH DARATUMUMAB
    Diaz, Galvez Francisco J.
    Barrigon Fernando, Escalante
    Vals Julio, Davila
    Saavedra Veronica, Campuzano
    Gomez Jorge, Labrador
    Garcia Abelardo, Barez
    Maria Del Carmen, Hermoso Martinez
    Nuno Rodolfo, Alvarez
    HAEMATOLOGICA, 2021, 106 (10) : 140 - 141
  • [22] Immune prognostic score predicts the risk of infection and survival outcomes in patients with relapsed multiple myeloma treated with bispecific antibodies
    Akhtar, Othman Salim
    Szabo, Aniko
    Bhatlapenumarthi, Vineel
    Forsberg, Mark
    Balev, Metodi
    Patwari, Anannya
    Cheruvalath, Heloise
    Bhutani, Divaya
    Thanendrarajan, Sharmilan
    Dhakal, Binod
    Zangari, Maurizio
    Patel, Tanvi
    Shrestha, Asis
    Al-Hadidi, Samer
    Cooper, Dennis
    Lentzsch, Suzanne
    van Rhee, Frits
    Shah, Mansi R.
    Bag, Aishee
    D'Souza, Anita
    Schinke, Carolina
    Chakraborty, Rajshekhar
    Shah, Nishi
    Mohan, Meera
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (05) : 1830 - 1834
  • [23] Pooled Analysis on Bispecific Antibody-Related Toxicities in Multiple Myeloma
    Golmohammadi, Mobina
    Dima, Danai
    Albayyadhi, Maram
    Moradi, Azam
    Raza, Shahzad
    Jaberi-Douraki, Majid
    BLOOD, 2023, 142
  • [24] Ferritin Dynamics are Associated with Clinical Outcomes of Multiple Myeloma Patients Receiving Bispecific Antibodies
    Mouhieddine, Tarek
    Sheng, Tianxiang
    Costa, Bruno
    Saffran, Nathaniel
    Pan, Darren
    Thibaud, Santiago
    Sanchez, Larysa
    Richard, Shambavi
    Rossi, Adriana
    Cho, Hearn Jay
    Richter, Joshua
    Rodriguez-Valdes, Cesar
    Chari, Ajai
    Parekh, Samir
    Moshier, Erin
    Jagannath, Sundar
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S75 - S75
  • [25] Monoclonal and Bispecific Anti-BCMA Antibodies in Multiple Myeloma
    Dalla Palma, Benedetta
    Marchica, Valentina
    Catarozzo, Maria Teresa
    Giuliani, Nicola
    Accardi, Fabrizio
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (09) : 1 - 11
  • [26] T-CELL BISPECIFIC ANTIBODIES SUPPRESS MULTIPLE MYELOMA
    Seckinger, A.
    Delgado, J. A.
    Moser, S.
    Moreno, L.
    Neuber, B.
    Grab, A.
    Li, J.
    Stagg, N. J.
    Johnston, J.
    Harris, M. J.
    Menzies, S. A.
    DiCara, D.
    CANCER DISCOVERY, 2017, 7 (05) : 452 - 452
  • [27] Clinical Outcomes of Relapsed/Refractory Multiple Myeloma Patients Following Treatment with Bispecific Antibodies (BiAbs)
    Mouhieddine, Tarek H.
    Van Oekelen, Oliver
    Pan, Darren
    Agte, Sarita
    Aleman, Adolfo
    Melnekoff, David T.
    Lancman, Guido
    Thibaud, Santiago
    Sanchez, Larysa
    Richard, Shambavi
    Richter, Joshua
    Cho, Hearn Jay
    Chari, Ajai
    Jagannath, Sundar
    Parekh, Samir
    BLOOD, 2021, 138
  • [28] Management of Toxicities Associated with BCMA, GPRC5D, and FcRH5-Targeting Bispecific Antibodies in Multiple Myeloma
    Pan, Darren
    Richter, Joshua
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2024, 19 (06) : 237 - 245
  • [29] T-cell-redirecting bispecific antibodies in multiple myeloma: a revolution?
    Moreau, Philippe
    Touzeau, Cyrille
    BLOOD, 2022, 139 (26) : 3681 - 3687
  • [30] The Role of Bispecific Antibodies in Relapsed Refractory Multiple Myeloma: A Systematic Review
    Khanam, Razwana
    Ashruf, Omer S.
    Bin Waqar, Syed Hamza
    Shah, Zunairah
    Batool, Saba
    Mehreen, Rameesha
    Pachika, Pranali
    Roksana, Zinath
    Rehman, Mohammad Ebad Ur
    Anwer, Faiz
    ANTIBODIES, 2023, 12 (02)
12345